Rodriguez and Potter (2013) used small interfering RNA (siRNA) in MCF7 and MDA-MB-231 breast cancer cells to knockdown CYP1A1 in order to investigate the role of this enzyme in breast cancer progression [45]. Here, CYP1A1 is linked to breast carcinoma.